ArticleScientific reports2024
Development of novel reduced graphene oxide/metalloporphyrin nanocomposite with photocatalytic and antimicrobial activity for potential wastewater treatment and medical applications.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Silver-coated Zea mays L. nanocatalyst for efficient Azo dye photodegradation and antimicrobial applications.Scientific reports · 2025Article
- Synergistic effect of porphyrin and NiO in chitosan/graphene oxide aerogels for enhanced photocatalytic degradation of cationic and anionic dyes.RSC advances · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This research investigates a novel nanocomposite material composed of reduced graphene oxide (rGO) and nickel-5,15-bisdodecylporphyrin (Ni-BDP) nanoparticles for the effective removal of methyl orange (MO), a harmful synthetic dye, from water. The structure and composition of the synthesized rGO/Ni-BDP nanocomposite were characterized using high-resolution transmission electron microscopy (HR-TEM), Raman spectroscopy, nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and ultraviolet-visible (UV-Vis) spectroscopy. The study demonstrates the material's efficacy as both a catalyst and adsorbent for MO removal. Optimal performance was observed at pH 3.0, where the positively charged nanocomposite surface facilitated strong interactions with negatively charged MO molecules, leading to enhanced photocatalytic activity. Under these conditions, 0.01 g of the nanocomposite achieved an impressive 86.2% MO removal efficiency. Furthermore, the study explored the reusability of the rGO/Ni-BDP nanocomposite in repeated cycles of photocatalytic MO degradation under visible light irradiation. While exhibiting some decrease in efficiency over five cycles, the nanocomposite maintained a respectable degradation rate even after multiple uses. Finally, the antimicrobial properties of the nanocomposite were evaluated against both Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) bacteria exhibiting a zone of inhibition measuring 23 mm and 26, respectively. The minimum inhibitory concentration (MIC) values of 2.50 µg/ml and 1.25 µg/ml for Escherichia coli and Staphylococcus aureus, respectively. The results revealed significant antibacterial activity, demonstrating the broad-spectrum efficacy of the rGO/Ni-BDP nanocomposite. This research underscores the potential of the rGO/Ni-BDP nanocomposite as a versatile material for environmental remediation and antibacterial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.